However, in another previous study conducted by Aclavicek et al. 22, the genetic variations in the major mitotic checkpoint genes, including MAD1L1 and MAD2L1, were found not to be significantly associated with the risk of familial breast cancer risk. The gene discussed is MAD2L1; the disease is breast carcinoma.